Health TrialsbyHealthPanel

Observational Study of Travellers Pathologies

ConditionTravel-Related Illness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut Pasteur

About this trial

Traveling to emerging countries is associated with a significant risk of encountering health issues specific to the destination, such as gastrointestinal and respiratory infections, malaria episodes, and road traffic accidents.These conditions are associated with behavioral, geographical, or environmental risk factors. A better understanding of these factors will enable the development of targeted recommendations to minimize travel related health issues.

The main objective of this study is to determine the incidence of pathologies occurring during travel outside the metropolitan territory.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Major subject (age ≥ 18)

Owns a smartphone compatible with electronic data collection

Preparing to travel outside mainland France

Affiliated with or covered by Social Security or private insurance

Disqualifiers

Travel duration ≤ 3 days

Travel duration > 12 months

Person traveling as part of an expatriation without planned movement outside the settlement in the destination country

Person under legal protection or unable to express consent for participation

Trial design

Design model

Single group

Treatments tested in this trial

  • Blood sample collection

    Other intervention

    16 mL at inclusion 16 mL at 1 month after return from travel

  • Fecal sample collection

    Other intervention

    1 sample at inclusion 1 sample at day 1, day 7, day 14, day 21, 1 month and 2 month after return from travel

Treatment groups

11,000 Participants
are divided into 1 treatment group
Group A: Adults planning to travel outside metropolitan France.Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Determine the incidence of pathologies occurring during a travel outside the metropolitan territory.

Number of subjects who developed a pathology during the travel among participants

Time frame
10 years

Secondary outcomes

1

For EOP-Arbo sub-study : Determine the prevalence for the occurrence of an arboviral disease (dengue, chikungunya, Zika) during the travel.

Number of arboviral diseases (dengue, chikungunya, Zika) during the travel among participants

Time frame
10 years
2

For EOP-AMR sub-study : Determine the prevalence for the acquisition of multi-resistant bacteria (MRB) during the travel.

Proportion of subjects with multi-resistant bacteria acquired during the travel

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Institut Pasteur

Lead sponsor

Source ClinicalTrials.gov
Apply now